Employer-Paid

The Centers for Medicare & Medicaid Services' final rule aims to stop brokers from steering beneficiaries to certain plans in exchange for higher reimbursement from insurers, while giving them more predictable compensation.

Recognizing the value of personalized spending in navigating such a pivotal life event is a crucial step toward equality and wellness in the workplace.

In a recent speech, President Biden overstated the average monthly cost that patients were paying prior to the Inflation Reduction Act: The out-of-pocket cost for insulin was $58 for a 30-day supply, says a HHS report.

Novo Nordisk's list price for a monthly package of Ozempic is $935.77 before insurance and other rebates, yet it can be manufactured for between $0.89 to $4.73 a month, according to researchers at Yale University.

Increasingly, health system consolidations, which must balance short-term and long-term financial goals, are focused on value-based care, which promotes better care for patients and improved health outcomes at reduced prices.

The Biden administration has announced that it has finalized a new regulation that curbs the use of short-term health insurance plans that do not comply with the Affordable Care Act, limiting the plans to 90 days.

The feds face a year-end deadline to solidify or scuttle payment changes for telehealth services that allow people to "visit" a doctor in their homes, however, it's expected that Congress will "kick the can" past the November election.

"Employers can reduce benefits expenses while simultaneously boosting employee engagement by implementing cost-effective and impactful benefits strategies," says Leia Spoor, clinical director of employee benefits of Holmes Murphy.